Whole Blood Gene Expression Reveals Specific Transcriptome Changes in Neonatal Encephalopathy

Fecha de publicación:

Autores de IIS La Fe

  • David Hervás Marín

    Autor

  • Inés Calabria Torres

    Autor

  • Máximo Vento Torres

    Autor

Participantes ajenos a IIS La Fe

  • Montaldo, Paolo
  • Kaforou, Myrsini
  • Pollara, Gabriele
  • Panadero, Joaquin
  • Lally, Peter J.
  • Oliveira, Vania
  • Kage, Anup
  • Atreja, Gaurav
  • Mendoza, Josephine
  • Soe, Aung
  • Pattnayak, Santosh
  • Shankaran, Seetha
  • Herberg, Jethro
  • Thayyil, Sudhin

Grupos

Abstract

Background: Variable responses to hypothermic neuroprotection are related to the clinical heterogeneity of encephalopathic babies; hence better disease stratification may facilitate the development of individualized neuroprotective therapies. Objectives: We examined if whole blood gene expression analysis can identify specific transcriptome profiles in neonatal encephalopathy. Material and Methods: We performed next-generation sequencing on whole blood RNA from 12 babies with neonatal encephalopathy and 6 time-matched healthy term babies. Genes significantly differentially expressed between encephalopathic and control babies were identified. This set of genes was then compared to the host RNA response in septic neonates and subjected to pathway analysis. Results: We identified 950 statistically significant genes discriminating perfectly between healthy controls and neonatal encephalopathy. The major pathways in neonatal encephalopathy were axonal guidance signaling (p = 0.0009), granulocyte adhesion and diapedesis (p = 0.003), IL-12 signaling and production in macrophages (p = 0.003), and hypoxia-inducible factor 1 alpha signaling (p = 0.004). There were only 137 genes in common between neonatal encephalopathy and bacterial sepsis sets. Conclusion: Babies with neonatal encephalopathy have striking differences in gene expression profiles compared with healthy control and septic babies. Gene expression profiles may be useful for disease stratification and for developing personalized neuroprotective therapies. (C) The Author(s). Published by S. Karger AG, Basel

Datos de la publicación

ISSN/ISSNe:
1661-7800, 1661-7819

Neonatology  KARGER

Tipo:
Article
Páginas:
68-76
PubMed:
30304723
Factor de Impacto:
1,178 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 20

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Neonatal encephalopathy; Gene expression; Brain injury; Biomarkers

Cita

Compartir